nach oben

Graefe's Archive for Clinical and Experimental Ophthalmology

Erschienen in:

13.03.2019 | Oncology

Risk factors for failure of vitrectomy cell block technique in cytological diagnosis of vitreoretinal lymphoma

verfasst von: Takako Ito, Atsunobu Takeda, Kohta Fujiwara, Eiichi Hasegawa, Shintaro Nakao, Yoshihiro Ohishi, Yoshinao Oda, Hiroshi Yoshikawa, Koh-Hei Sonoda

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the factors that may affect the accuracy of vitrectomy cell block technique in detecting atypical lymphoid cells in patients with vitreoretinal lymphoma (VRL).

Methods

We retrospectively reviewed 43 eyes in 39 patients who underwent vitrectomy for definitive histological diagnosis of VRL with vitrectomy cell block technique and/or smear preparation at Kyushu University Hospital from January 2001 to March 2016. The association of detection of atypical lymphoid cells using vitrectomy cell block technique with the following factors was assessed using logistic regression analysis: age at diagnosis, sex, presence or absence of concurrent cataract surgery with vitrectomy, clinical grading of vitreous haze, presence or absence of subretinal tumor infiltration, interval between initial symptoms and vitrectomy, and presence or absence of systemic corticosteroid therapy before vitrectomy.

Results

Atypical lymphoid cells were more significantly detected using vitrectomy cell block technique compared to that using smear preparation (p = 0.018). After adjusting for age and sex, concurrent cataract surgery (odds ratio [OR], 10.41; 95% confidence interval [CI], 1.42–76.41) and subretinal tumor infiltration (OR, 5.06; 95% CI, 1.06–24.32) were significantly associated with failure of histological analysis with vitrectomy cell blocks. In multivariable logistic regression analysis, similar results were obtained, although subretinal tumor infiltration was only marginally associated with the detective capability of the technique.

Conclusion

Vitrectomy cell block technique significantly improved the definitive diagnosis of VRL. Concurrent cataract surgery with vitrectomy and subretinal tumor infiltration were risk factors for failure in vitrectomy cell blocks.

Coupland SE, Chan CC, Smith J (2009) Pathophysiology of retinal lymphoma. Ocul Immunol Inflamm 17:227–237. https://doi.org/10.1080/09273940903168696 CrossRefPubMedPubMedCentral

Faia LJ, Chan CC (2009) Primary intraocular lymphoma. Arch Pathol Lab Med 133:1228–1232. https://doi.org/10.1043/1543-2165-133.8.1228 CrossRefPubMedPubMedCentral

Chan CC, Buggage RR, Nussenblatt RB (2002) Intraocular lymphoma. Curr Opin Ophthalmol 13:411–418CrossRefPubMed

Chan CC, Sen HN (2013) Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma. Discov Med 15:93–100PubMedPubMedCentral

Kimura K, Usui Y, Goto H (2012) Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Jpn J Ophthalmol 56:383–389. https://doi.org/10.1007/s10384-012-0150-7 CrossRefPubMed

Akpek EK, Ahmed I, Hochberg FH, Soheilian M, Dryja TP, Jakobiec FA, Foster CS (1999) Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology 106:1805–1810. https://doi.org/10.1016/S0161-6420(99)90341-X CrossRefPubMed

Coupland SE, Heimann H, Bechrakis NE (2004) Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol 242:901–913. https://doi.org/10.1007/s00417-004-0973-0 CrossRefPubMed

Hashida N, Nakai K, Saitoh N, Nishida K (2014) Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma. Graefes Arch Clin Exp Ophthalmol 252:687–693. https://doi.org/10.1007/s00417-014-2584-8 CrossRefPubMed

Fend F, Ferreri AJ, Coupland SE (2016) How we diagnose and treat vitreoretinal lymphoma. Br J Haematol 173:680–692. https://doi.org/10.1111/bjh.14025 CrossRefPubMed

10.

Ma WL, Hou HA, Hsu YJ, Chen YK, Tang JL, Tsay W, Yeh PT, Yang CM, Lin CP, Tien HF (2016) Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection. Ann Hematol 95:593–601. https://doi.org/10.1007/s00277-015-2582-x CrossRefPubMed

11.

Akiyama H, Takase H, Kubo F, Miki T, Yamamoto M, Tomita M, Mochizuki M, Miura O, Arai A (2016) High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma. Cancer Sci 107:1458–1464. https://doi.org/10.1111/cas.13012 CrossRefPubMedPubMedCentral

12.

Kaburaki T, Taoka K, Matsuda J, Yamashita H, Matsuda I, Tsuji H, Tanaka R, Nakazaki K, Nakamura F, Kamiya K, Kurokawa M, Ohtomo K, Aihara M (2017) Combined intravitreal methotrexate and immunochemotherapy followed by reduced-dose whole-brain radiotherapy for newly diagnosed B-cell primary intraocular lymphoma. Br J Haematol 179:246–255. https://doi.org/10.1111/bjh.14848 CrossRefPubMed

13.

Kreher S, Strehlow F, Martus P, Roth P, Hertenstein B, Roth A, Birnbaum T, Griesinger F, Rauch M, Kanz L, Thiel E, Weller M, Korfel A (2015) Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trial. Ann Hematol 94:409–414. https://doi.org/10.1007/s00277-014-2212-z CrossRefPubMed

14.

Lee S, Kim MJ, Kim JS, Oh SY, Kim SJ, Kwon YH, Chung IY, Kang JH, Yang DH, Kang HJ, Yoon DH, Kim WS, Kim HJ, Suh C (2015) Intraocular lymphoma in Korea: the consortium for improving survival of lymphoma (CISL) study. Blood Res 50:242–247. https://doi.org/10.5045/br.2015.50.4.242 CrossRefPubMedPubMedCentral

15.

Cheah CY, Milgrom S, Chihara D, Gombos DS, Pinnix CC, Dabaja BS, Fowler NH (2016) Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma. Neuro-Oncology 18:575–581. https://doi.org/10.1093/neuonc/nov253 CrossRefPubMed

16.

Davis JL, Miller DM, Ruiz P (2005) Diagnostic testing of vitrectomy specimens. Am J Ophthalmol 140:822–829. https://doi.org/10.1016/j.ajo.2005.05.032 CrossRefPubMed

17.

Margolis R, Brasil OF, Lowder CY, Singh RP, Kaiser PK, Smith SD, Perez VL, Sonnie C, Sears JE (2007) Vitrectomy for the diagnosis and management of uveitis of unknown cause. Ophthalmology 114:1893–1897. https://doi.org/10.1016/j.ophtha.2007.01.038 CrossRefPubMed

18.

Oahalou A, Schellekens PA, de Groot-Mijnes JD, Rothova A (2014) Diagnostic pars plana vitrectomy and aqueous analyses in patients with uveitis of unknown cause. Retina 34:108–114. https://doi.org/10.1097/IAE.0b013e31828e6985 CrossRefPubMed

19.

Whitcup SM, Stark-Vancs V, Wittes RE, Solomon D, Podgor MJ, Nussenblatt RB, Chan CC (1997) Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Arch Ophthalmol 115:1157–1160CrossRefPubMed

20.

Baehring JM, Androudi S, Longtine JJ, Betensky RA, Sklar J, Foster CS, Hochberg FH (2005) Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma. Cancer 104:591–597. https://doi.org/10.1002/cncr.21191 CrossRefPubMed

21.

Sugita S, Takase H, Sugamoto Y, Arai A, Miura O, Mochizuki M (2009) Diagnosis of intraocular lymphoma by polymerase chain reaction analysis and cytokine profiling of the vitreous fluid. Jpn J Ophthalmol 53:209–214. https://doi.org/10.1007/s10384-009-0662-y CrossRefPubMed

22.

Davis JL, Viciana AL, Ruiz P (1997) Diagnosis of intraocular lymphoma by flow cytometry. Am J Ophthalmol 124:362–372CrossRefPubMed

23.

Intzedy L, Teoh SC, Hogan A, Mangwana S, Mayer EJ, Dick AD, Pawade J (2008) Cytopathological analysis of vitreous in intraocular lymphoma. Eye (London) 22:289–293. https://doi.org/10.1038/sj.eye.6702965 CrossRef

24.

Zaldivar RA, Martin DF, Holden JT, Grossniklaus HE (2004) Primary intraocular lymphoma: clinical, cytologic, and flow cytometric analysis. Ophthalmology 111:1762–1767. https://doi.org/10.1016/j.ophtha.2004.03.021 CrossRefPubMed

25.

Matsuo T, Ichimura K (2012) Immunocytochemical diagnosis as inflammation by vitrectomy cell blocks in patients with vitreous opacity. Ophthalmology 119:827–837. https://doi.org/10.1016/j.ophtha.2011.10.020 CrossRef

26.

Kase S, Namba K, Iwata D, Mizuuchi K, Kitaichi N, Tagawa Y, Okada-Kanno H, Matsuno Y, Ishida S (2016) Diagnostic efficacy of cell block method for vitreoretinal lymphoma. Diagn Pathol 11:29. https://doi.org/10.1186/s13000-016-0479-1 CrossRefPubMedPubMedCentral

27.

Feng H, Adelman RA (2014) Cataract formation following vitreoretinal procedures. Clin Ophthalmol 8:1957–1965. https://doi.org/10.2147/OPTH.S68661 CrossRefPubMedPubMedCentral

28.

Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140:509–516CrossRef

29.

Chan CC, Rubenstein JL, Coupland SE, Davis JL, Harbour JW, Johnston PB, Cassoux N, Touitou V, Smith JR, Batchelor TT, Pulido JS (2011) Primary vitreoretinal lymphoma: a report from an international primary central nervous system lymphoma collaborative group symposium. Oncologist 16:1589–1599. https://doi.org/10.1634/theoncologist.2011-0210 CrossRefPubMedPubMedCentral

30.

Taki R, Takeda A, Yoshikawa H, Fukuhara T, Arita R, Suehiro Y, Choi I, Kumano Y, Nakamura T, Ishibashi T (2017) Clinical features of systemic metastatic retinal lymphoma in Japanese patients. Ocul Immunol Inflamm 25:654–662. https://doi.org/10.3109/09273948.2016.1151894 CrossRefPubMed

31.

Takeda A, Yoshikawa H, Fukuhara T, Hikita S, Hijioka K, Otomo T, Arita R, Hisatomi T, Kimura K, Yoshida S, Kawano Y, Sonoda KH, Ishibashi T (2015) Distinct profiles of soluble cytokine receptors between B-cell vitreoretinal lymphoma and uveitis. Invest Ophthalmol Vis Sci 56:7516–7523. https://doi.org/10.1167/iovs.15-17465 CrossRefPubMed

32.

Wakefield D, Zierhut M (2009) Intraocular lymphoma: more questions than answers. Ocul Immunol Inflamm 17:6–10. https://doi.org/10.1080/09273940902834413 CrossRefPubMed

33.

Char DH, Ljung BM, Miller T, Phillips T (1988) Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology 95:625–630CrossRefPubMed

34.

Mayall F, Chang B, Darlington A (1997) A review of 50 consecutive cytology cell block preparations in a large general hospital. J Clin Pathol 50:985–990CrossRefPubMedPubMedCentral

35.

Sakamoto T, Miyazaki M, Hisatomi T, Nakamura T, Ueno A, Itaya K, Ishibashi T (2002) Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol 240:423–429. https://doi.org/10.1007/s00417-002-0454-2 CrossRefPubMed

36.

Michael R, Bron AJ (2011) The ageing lens and cataract: a model of normal and pathological ageing. Philos Trans R Soc Lond Ser B Biol Sci 366:1278–1292. https://doi.org/10.1098/rstb.2010.0300 CrossRef

37.

Davis JL, Ruiz P Jr, Shah M, Mandelcorn ED (2012) Evaluation of the reactive T-cell infiltrate in uveitis and intraocular lymphoma with flow cytometry of vitreous fluid (an American ophthalmological society thesis). Trans Am Ophthalmol Soc 110:117–129PubMedPubMedCentral

38.

Sagoo MS, Mehta H, Swampillai AJ, Cohen VM, Amin SZ, Plowman PN, Lightman S (2014) Primary intraocular lymphoma. Surv Ophthalmol 59:503–516. https://doi.org/10.1016/j.survophthal.2013.12.001 CrossRefPubMed

39.

Bonzheim I, Giese S, Deuter C, Susskind D, Zierhut M, Waizel M, Szurman P, Federmann B, Schmidt J, Quintanilla-Martinez L, Coupland SE, Bartz-Schmidt KU, Fend F (2015) High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates. Blood 126:76–79. https://doi.org/10.1182/blood-2015-01-620518 CrossRefPubMed

40.

Raja H, Salomao DR, Viswanatha DS, Pulido JS (2016) Prevalence of Myd88 L265p mutation in histologically proven, diffuse large B-cell vitreoretinal lymphoma. Retina 36:624–628. https://doi.org/10.1097/IAE.0000000000000996 CrossRefPubMed

41.

Cani AK, Hovelson DH, Demirci H, Johnson MW, Tomlins SA, Rao RC (2017) Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies. Oncotarget 8:7989–7998. https://doi.org/10.18632/oncotarget.14008 CrossRefPubMed

Titel: Risk factors for failure of vitrectomy cell block technique in cytological diagnosis of vitreoretinal lymphoma
verfasst von: Takako Ito
Atsunobu Takeda
Kohta Fujiwara
Eiichi Hasegawa
Shintaro Nakao
Yoshihiro Ohishi
Yoshinao Oda
Hiroshi Yoshikawa
Koh-Hei Sonoda
Publikationsdatum: 13.03.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 5/2019
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-019-04266-6

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Risk factors for failure of vitrectomy cell block technique in cytological diagnosis of vitreoretinal lymphoma

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2019

Peripapillary and macular morpho-vascular changes in patients with genetic or clinical diagnosis of autosomal dominant optic atrophy: a case-control study

Simulators in the training of surgeons: is it worth the investment in money and time? 2018 Jules Gonin lecture of the Retina Research Foundation

Investigating retinal toxicity of a lutein-based dye in a model of isolated and perfused bovine retina

Age-related differences in the prevalence of subtypes of Neovascular age-related macular degeneration in the first diagnosed eye

Endothelial cell density and corneal graft thickness following excimer laser vs. femtosecond laser-assisted penetrating keratoplasty—a prospective randomized study

Effectiveness of multifocal and monofocal intraocular lenses for cataract surgery and lens replacement: a systematic review and meta-analysis

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde